Editorial: Targeted alpha particle therapy in oncology.

Bruland, Øyvind Sverre; Larsen, Roy Hartvig; Baum, Richard Paul; Juzeniene, Asta

Bruland, Øyvind Sverre; Larsen, Roy Hartvig; Baum, Richard Paul; Juzeniene, Asta.

Affiliation

Bruland ØS; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Larsen RH; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Baum RP; Sciencons AS, Oslo, Norway.
Juzeniene A; Curanosticum Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.

Front Med (Lausanne) ; 10: 1165747, 2023.

Article in En | MEDLINE | ID: mdl-36960341

Key words

actinium-225; astatine-211; lead-212; radium-223; radium-224; targeted alpha therapy (TAT); targeted radionuclide therapy (TRT); thorium-227

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country: Noruega

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country: Noruega